Concise genetic profile of lung carcinoma
- 2 June 2021
- journal article
- review article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 99 (1170) , 265-271
Abstract
The WHO classification of lung cancer (2015) is based on immunohistochemistry and molecular evaluation. This also includes microscopic analysis of morphological patterns that aids in the pathological diagnosis and classification of lung cancers. Lung cancers are the leading cause of cancer deaths worldwide. Recent advancements in identifying the etiopathogenesis are majorly driven by gene mutation studies. This has been explained by The Cancer Genome Atlas, next-generation sequencer and TRAcking non-small cell lung cancer evolution through therapy [Rx]. This article reviews the genetic profile of adenocarcinoma, squamous cell carcinoma, small cell carcinoma, large cell neuroendocrine carcinoma and pulmonary carcinoids. This includes the prolific genetic alterations and novel molecular changes seen in these tumours. In addition, target- specific drugs that have shown promising effects in clinical use and trials are also briefly discussed.Keywords
This publication has 52 references indexed in Scilit:
- The role of p53 in cancer drug resistance and targeted chemotherapyOncotarget, 2016
- Comparative safety of BRAF and MEK inhibitors (vemurafenib, dabrafenib and trametinib) in first-line therapy for BRAF-mutated metastatic melanomaMolecular and Clinical Oncology, 2016
- SETD2: an epigenetic modifier with tumor suppressor functionalityOncotarget, 2016
- Tumor-Suppressor Functions of the TP53 PathwayCold Spring Harbor Perspectives in Medicine, 2016
- ALK inhibitors in non-small cell lung cancer: the latest evidence and developmentsTherapeutic Advances in Medical Oncology, 2015
- Targeted Therapies in Non-Small Cell Lung Cancer—Beyond EGFR and ALKCancers, 2015
- Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledgeContemporary Oncology, 2015
- Comprehensive Pathological Analyses in Lung Squamous Cell Carcinoma: Single Cell Invasion, Nuclear Diameter, and Tumor Budding Are Independent Prognostic Factors for Worse OutcomesJournal of Thoracic Oncology, 2014
- Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesisEndocrine-Related Cancer, 2014
- The role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lung2013